A perfect islet: reviewing recent protocol developments and proposing strategies for stem cell derived functional pancreatic islets
Open Access
- 31 March 2025
- journal article
- review article
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 16 (1) , 1-19
Abstract
The search for an effective cell replacement therapy for diabetes has driven the development of “perfect” pancreatic islets from human pluripotent stem cells (hPSCs). These hPSC-derived pancreatic islet-like β cells can overcome the limitations for disease modelling, drug development and transplantation therapies in diabetes. Nevertheless, challenges remain in generating fully functional and mature β cells from hPSCs. This review underscores the significant efforts made by researchers to optimize various differentiation protocols aimed at enhancing the efficiency and quality of hPSC-derived pancreatic islets and proposes methods for their improvement. By emulating the natural developmental processes of pancreatic embryogenesis, specific growth factors, signaling molecules and culture conditions are employed to guide hPSCs towards the formation of mature β cells capable of secreting insulin in response to glucose. However, the efficiency of these protocols varies greatly among different human embryonic stem cell (hESC) and induced pluripotent stem cell (hiPSC) lines. This variability poses a particular challenge for generating patient-specific β cells. Despite recent advancements, the ultimate goal remains to develop a highly efficient directed differentiation protocol that is applicable across all genetic backgrounds of hPSCs. Although progress has been made, further research is required to optimize the protocols and characterization methods that could ensure the safety and efficacy of hPSC-derived pancreatic islets before they can be utilized in clinical settings.Keywords
This publication has 157 references indexed in Scilit:
- Deletion of RFX6 impairs iPSC-derived islet organoid development and survival, with no impact on PDX1+/NKX6.1+ progenitorsDiabetologia, 2024
- RFX6 haploinsufficiency predisposes to diabetes through impaired beta cell functionDiabetologia, 2024
- Derivation of Endodermal Progenitors From Pluripotent Stem CellsJournal of Cellular Physiology, 2014
- Notch signaling in the pancreas: patterning and cell fate specificationWIREs Developmental Biology, 2012
- Sustained expression of the transcription factor GLIS3 is required for normal beta cell function in adultsEMBO Molecular Medicine, 2012
- Brief Report: Benchmarking Human Pluripotent Stem Cell Markers During Differentiation Into the Three Germ Layers Unveils a Striking Heterogeneity: All Markers Are Not EqualStem Cells, 2011
- Paired box 6 (PAX6) regulates glucose metabolism via proinsulin processing mediated by prohormone convertase 1/3 (PC1/3)Diabetologia, 2008
- Transcription factor expression in the developing human fetal endocrine pancreasDiabetologia, 2008
- Ex vivo analysis of acinar and endocrine cell development in the human embryonic pancreasDevelopmental Dynamics, 2005
- NeuroD1 in the endocrine pancreas: Localization and dual function as an activator and repressorDevelopmental Dynamics, 2005